Auna S.A. (AUNA)vsJohnson & Johnson (JNJ)
AUNA
Auna S.A.
$5.07
-0.78%
HEALTHCARE · Cap: $375.47M
JNJ
Johnson & Johnson
$229.85
+1.10%
HEALTHCARE · Cap: $547.28B
Smart Verdict
WallStSmart Research — data-driven comparison
Johnson & Johnson generates 2097% more annual revenue ($96.36B vs $4.39B). JNJ leads profitability with a 21.8% profit margin vs 2.2%. AUNA trades at a lower P/E of 13.7x. JNJ earns a higher WallStSmart Score of 59/100 (C).
AUNA
Hold48
out of 100
Grade: D+
JNJ
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AUNA.
Margin of Safety
-43.5%
Fair Value
$160.13
Current Price
$229.85
$69.72 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Mega-cap, among the largest globally
Every $100 of equity generates 26 in profit
Keeps 22 of every $100 in revenue as profit
Strong operational efficiency at 27.4%
Generating 1.5B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
ROE of 6.5% — below average capital efficiency
2.2% margin — thin
Earnings declined 50.9%
Moderate valuation
Expensive relative to growth rate
Earnings declined 52.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : AUNA
The strongest argument for AUNA centers on Price/Book, P/E Ratio.
Bull Case : JNJ
The strongest argument for JNJ centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 21.8% and operating margin at 27.4%.
Bear Case : AUNA
The primary concerns for AUNA are Market Cap, Return on Equity, Profit Margin. Debt-to-equity of 2.23 is elevated, increasing financial risk. Thin 2.2% margins leave little buffer for downturns.
Bear Case : JNJ
The primary concerns for JNJ are P/E Ratio, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
AUNA profiles as a value stock while JNJ is a mature play — different risk/reward profiles.
AUNA carries more volatility with a beta of 1.64 — expect wider price swings.
JNJ is growing revenue faster at 9.9% — sustainability is the question.
JNJ generates stronger free cash flow (1.5B), providing more financial flexibility.
Bottom Line
JNJ scores higher overall (59/100 vs 48/100), backed by strong 21.8% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Auna S.A.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Auna S.A. is a prominent telecommunications and digital services provider in Latin America, specializing in integrated solutions that enhance connectivity and customer experience. With a comprehensive portfolio that includes high-speed internet, television, and mobile services, Auna caters to both residential and business clients across a variety of markets. The company's dedication to innovation and exceptional customer service has established it as a key player in the region's dynamic digital landscape. Its extensive and robust infrastructure positions Auna favorably to leverage the growing demand for advanced telecom solutions, presenting significant growth opportunities for institutional investors.
Visit Website →Johnson & Johnson
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?